272 related articles for article (PubMed ID: 20950580)
1. [Guidelines for the production, control and regulation of snake antivenom immunoglobulins].
Chippaux JP
Biol Aujourdhui; 2010; 204(1):87-91. PubMed ID: 20950580
[TBL] [Abstract][Full Text] [Related]
2. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
[TBL] [Abstract][Full Text] [Related]
3. Snakebite envenoming from a global perspective: Towards an integrated approach.
Gutiérrez JM; Williams D; Fan HW; Warrell DA
Toxicon; 2010 Dec; 56(7):1223-35. PubMed ID: 19951718
[TBL] [Abstract][Full Text] [Related]
4. Needs and availability of snake antivenoms: relevance and application of international guidelines.
Scheske L; Ruitenberg J; Bissumbhar B
Int J Health Policy Manag; 2015 Apr; 4(7):447-57. PubMed ID: 26188809
[TBL] [Abstract][Full Text] [Related]
5. [Emergency immunotherapy: snake and scorpion antivenoms].
Chippaux JP
Biol Aujourdhui; 2010; 204(1):61-70. PubMed ID: 20950577
[TBL] [Abstract][Full Text] [Related]
6. Bringing antivenoms to Sub-Saharan Africa.
Stock RP; Massougbodji A; Alagón A; Chippaux JP
Nat Biotechnol; 2007 Feb; 25(2):173-7. PubMed ID: 17287747
[TBL] [Abstract][Full Text] [Related]
7. An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management.
Ainsworth S; Menzies SK; Casewell NR; Harrison RA
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008579. PubMed ID: 32817682
[TBL] [Abstract][Full Text] [Related]
8. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
[TBL] [Abstract][Full Text] [Related]
9. Reducing the impact of snakebite envenoming in Latin America and the Caribbean: achievements and challenges ahead.
Gutiérrez JM
Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):530-7. PubMed ID: 25096295
[TBL] [Abstract][Full Text] [Related]
10. Improving antivenom availability and accessibility: science, technology, and beyond.
Gutiérrez JM
Toxicon; 2012 Sep; 60(4):676-87. PubMed ID: 22781134
[TBL] [Abstract][Full Text] [Related]
11. Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy.
Keyler DE; Gawarammana I; Gutiérrez JM; Sellahewa KH; McWhorter K; Malleappah R
Toxicon; 2013 Jul; 69():90-7. PubMed ID: 23454626
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the Cross-Neutralisation Potential of Existing Antivenoms for Mitigating the Outcomes of Snakebite in Sub-Saharan Africa.
Khochare S; Jaglan A; Rashmi U; Dam P; Sunagar K
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673799
[TBL] [Abstract][Full Text] [Related]
13. Vulnerability to snakebite envenoming: a global mapping of hotspots.
Longbottom J; Shearer FM; Devine M; Alcoba G; Chappuis F; Weiss DJ; Ray SE; Ray N; Warrell DA; Ruiz de Castañeda R; Williams DJ; Hay SI; Pigott DM
Lancet; 2018 Aug; 392(10148):673-684. PubMed ID: 30017551
[TBL] [Abstract][Full Text] [Related]
14. Antivenoms for snakebite envenomings.
Gutiérrez JM; León G; Lomonte B; Angulo Y
Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181
[TBL] [Abstract][Full Text] [Related]
15. Report of a WHO workshop on the standardization and control of antivenoms.
Theakston RD; Warrell DA; Griffiths E
Toxicon; 2003 Apr; 41(5):541-57. PubMed ID: 12676433
[TBL] [Abstract][Full Text] [Related]
16. Omics meets biology: application to the design and preclinical assessment of antivenoms.
Calvete JJ; Sanz L; Pla D; Lomonte B; Gutiérrez JM
Toxins (Basel); 2014 Dec; 6(12):3388-405. PubMed ID: 25517863
[TBL] [Abstract][Full Text] [Related]
17. Snake antivenom production in Ecuador: Poor implementation, and an unplanned cessation leads to a call for a renaissance.
Ortiz-Prado E; Yeager J; Andrade F; Schiavi-Guzman C; Abedrabbo-Figueroa P; Terán E; Gómez-Barreno L; Simbaña-Rivera K; Izquierdo-Condoy JS
Toxicon; 2021 Oct; 202():90-97. PubMed ID: 34571098
[TBL] [Abstract][Full Text] [Related]
18. [An unusual mode of snake poisoning in Tunisia].
Chaari AN; Bahloul M; Tlijani M; Dammak H; Bouaziz M
Med Trop (Mars); 2010 Apr; 70(2):201-2. PubMed ID: 20486364
[TBL] [Abstract][Full Text] [Related]
19. Antibodies as Snakebite Antivenoms: Past and Future.
Dias da Silva W; De Andrade SA; Megale ÂAA; De Souza DA; Sant'Anna OA; Magnoli FC; Guidolin FR; Godoi KS; Saladini LY; Spencer PJ; Portaro FCV
Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136544
[TBL] [Abstract][Full Text] [Related]
20. Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop.
Gutiérrez JM; Fan HW; Silvera CL; Angulo Y
Toxicon; 2009 May; 53(6):625-30. PubMed ID: 19673076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
